9.86 USD
-0.09 (-0.9%)
9.84 USD
-0.02 (-0.2%)
We assign a fundamental rating of 3 out of 10 to RXST. RXST was compared to 186 industry peers in the Health Care Equipment & Supplies industry. The financial health of RXST is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RXST is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- RXST had negative earnings in the past year.
- In the past year RXST has reported a negative cash flow from operations.
- RXST had negative earnings in 4 of the past 5 years.
- RXST had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -11.58%, RXST perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
- With a decent Return On Equity value of -12.95%, RXST is doing good in the industry, outperforming 65.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.58% | ||
| ROE | -12.95% | ||
| ROIC | N/A |
ROA(3y)-26.56%
ROA(5y)-20.32%
ROE(3y)-38.11%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RXST has a Gross Margin of 74.98%. This is amongst the best in the industry. RXST outperforms 86.02% of its industry peers.
- RXST's Gross Margin has improved in the last couple of years.
- The Profit Margin and Operating Margin are not available for RXST so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.98% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y52.32%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RXST does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, RXST has more shares outstanding
- Compared to 5 years ago, RXST has more shares outstanding
- Compared to 1 year ago, RXST has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.50 indicates that RXST is not in any danger for bankruptcy at the moment.
- RXST has a Altman-Z score of 5.50. This is in the better half of the industry: RXST outperforms 78.49% of its industry peers.
- A Debt/Equity ratio of 0.00 indicates that RXST is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.00, RXST is doing good in the industry, outperforming 75.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.5 |
ROIC/WACCN/A
WACC10.02%
2.3 Liquidity
- A Current Ratio of 12.74 indicates that RXST has no problem at all paying its short term obligations.
- The Current ratio of RXST (12.74) is better than 96.24% of its industry peers.
- A Quick Ratio of 11.44 indicates that RXST has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 11.44, RXST belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.74 | ||
| Quick Ratio | 11.44 |
3. Growth
3.1 Past
- The earnings per share for RXST have decreased by -6.02% in the last year.
- The Revenue has grown by 10.75% in the past year. This is quite good.
- Measured over the past years, RXST shows a very strong growth in Revenue. The Revenue has been growing by 128.63% on average per year.
EPS 1Y (TTM)-6.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)10.75%
Revenue growth 3Y83.65%
Revenue growth 5Y128.63%
Sales Q2Q%-14.09%
3.2 Future
- Based on estimates for the next years, RXST will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.71% on average per year.
- Based on estimates for the next years, RXST will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y-54.42%
EPS Next 2Y-18.92%
EPS Next 3Y-8.67%
EPS Next 5Y18.71%
Revenue Next Year-7.37%
Revenue Next 2Y-1.79%
Revenue Next 3Y1.96%
Revenue Next 5Y3.37%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for RXST. In the last year negative earnings were reported.
- Also next year RXST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- RXST's earnings are expected to decrease with -8.67% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.92%
EPS Next 3Y-8.67%
5. Dividend
5.1 Amount
- RXST does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
RXSIGHT INC / RXST FAQ
What is the ChartMill fundamental rating of RXSIGHT INC (RXST) stock?
ChartMill assigns a fundamental rating of 3 / 10 to RXST.
What is the valuation status for RXST stock?
ChartMill assigns a valuation rating of 0 / 10 to RXSIGHT INC (RXST). This can be considered as Overvalued.
Can you provide the profitability details for RXSIGHT INC?
RXSIGHT INC (RXST) has a profitability rating of 2 / 10.
How financially healthy is RXSIGHT INC?
The financial health rating of RXSIGHT INC (RXST) is 6 / 10.
What is the earnings growth outlook for RXSIGHT INC?
The Earnings per Share (EPS) of RXSIGHT INC (RXST) is expected to decline by -54.42% in the next year.